ERANID
European Research Area Network on Illicit Drugs - Towards integrated European research in illicit drugs: cause and nature of drug problems; interventions and policies
| Coordinatore | THE NETHERLANDS ORGANISATION FOR HEALTH RESEARCH AND DEVELOPMENT
Organization address
address: Laan Van Nieuw Oost Indie 334 contact info |
| Nazionalità Coordinatore | Netherlands [NL] |
| Sito del progetto | http://www.eranid.eu/ |
| Totale costo | 2˙221˙128 € |
| EC contributo | 1˙999˙725 € |
| Programma | FP7-SSH
Specific Programme "Cooperation": Socio-economic Sciences and Humanities |
| Code Call | FP7-ERANET-2012-RTD |
| Funding Scheme | CSA-CA |
| Anno di inizio | 2013 |
| Periodo (anno-mese-giorno) | 2013-01-01 - 2016-12-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
THE NETHERLANDS ORGANISATION FOR HEALTH RESEARCH AND DEVELOPMENT
Organization address
address: Laan Van Nieuw Oost Indie 334 contact info |
NL (DEN HAAG) | coordinator | 628˙286.25 |
| 2 |
PRESIDENZA DEL CONSIGLIO DEI MINISTRI.
Organization address
address: Piazza Colonna 370 - Palazzo Chigi contact info |
IT (ROMA) | participant | 280˙066.00 |
| 3 |
SERVICE PUBLIC FEDERAL DE PROGRAMMATION POLITIQUE SCIENTIFIQUE
Organization address
address: avenue Louise 231 contact info |
BE (BRUSSELS) | participant | 248˙600.75 |
| 4 |
SERVICO DE INTERVENCAO NOS COMPORTAMENTOS ADITIVOS E NAS DEPENDENCIAS
Organization address
address: AVENIDA DA REPUBLICA 61 DO 1 AO 3 E DO 7 AO 9 contact info |
PT (LISBOA) | participant | 247˙745.00 |
| 5 |
LIVERPOOL JOHN MOORES UNIVERSITY
Organization address
address: Egerton Court Rodney Street 2 contact info |
UK (LIVERPOOL) | participant | 238˙075.00 |
| 6 |
OBSERVATOIRE FRANCAIS DES DROGUES ET DES TOXICOMANIES GIP*OFDT
Organization address
address: AVENUE DU STADE DE FRANCE 3 contact info |
FR (SAINT DENIS) | participant | 211˙218.00 |
| 7 |
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Organization address
address: Rue Michel -Ange 3 contact info |
FR (PARIS) | participant | 78˙645.00 |
| 8 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Organization address
address: 101 Rue de Tolbiac contact info |
FR (PARIS) | participant | 67˙089.00 |
| 9 |
"MINISTERIE VAN VOLKSGEZONDHEID, WELZIJN EN SPORT"
Organization address
address: PARNASSUSPLEIN 5 contact info |
NL (DEN HAAG) | participant | 0.00 |
| 10 |
Department of Health
Organization address
address: Quarry House, Quarry Hill contact info |
UK (Leeds) | participant | 0.00 |
| 11 |
HOME OFFICE
Organization address
address: 2 Marsham Street contact info |
UK (LONDON) | participant | 0.00 |
| 12 |
INSTITUTO DA DROGA E DA TOXICODEPENDENCIA
Organization address
city: Lisboa contact info |
PT (Lisboa) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'ERANID, the European Area Network on Illicit Drugs, aims to improve cooperation in drug research in order to allow well-founded policy decisions. ERANID works both in the demand field and in the supply field. ERANID will promote multidisciplinary research activities in the field of socio-economic sciences and humanities. This may cover e.g. emerging drugs, vulnerable groups, changing demographics of drug using populations, and the impact of drugs on health inequalities and social deprivation. It may also cover patterns in drug markets and the drug-crime nexus. Closer cooperation between researchers in different countries will also lead to a further development of research methodologies, which can be of special importance for the evaluation of policies and programmes. Overcoming fragmentation in drug research and developing a common Strategic Research Agenda (SRA) are key objectives of ERANID. To do this, ERANID will first take stock of research programmes and research projects. By making the results of this exercise easily accessible, ERANID will help researchers and policy makers to find information and avoid unnecessary duplication of research. ERANID will consult stakeholders (e.g. scientific community, treatment centre organisations, patient organisations, police and justice). Analysis of the results will help to find gaps and to set priorities for research that will profit most from an international and interdisciplinary approach. Bringing together funding bodies in EU Member States and other countries, involving policy makers and other stakeholders will help to create consensus about the research priorities. These issues will all inform the SRA, from which the priorities for two joint research calls will be selected. ERANID starts as a consortium of eleven partners from six EU Member States. Other organisations from a number of European and other countries will be kept closely informed and associated to this initiative. ERANID is meant as first step towards a longer term cooperation in the field of drugs research.'